{"id": 1483864631240237058, "geo": null, "lang": "en", "text": "RT @erinbrodwin: Scoop: Topography charts new trial path with $21.5m from a16z and Bain https://t.co/SL1MgmTVGm", "user": {"id": 800707492346925056, "url": "https://t.co/B5SXhPF5gM", "lang": null, "name": "Axios", "id_str": "800707492346925056", "entities": {"url": {"urls": [{"url": "https://t.co/B5SXhPF5gM", "indices": [0, 23], "display_url": "axios.com", "expanded_url": "https://www.axios.com"}]}, "description": {"urls": [{"url": "https://t.co/JCzYNLRRbk", "indices": [90, 113], "display_url": "bit.ly/3hMCmVn", "expanded_url": "https://bit.ly/3hMCmVn"}]}}, "location": "", "verified": true, "following": true, "protected": false, "time_zone": null, "created_at": "Mon Nov 21 14:28:37 +0000 2016", "utc_offset": null, "description": "Smart Brevity worthy of people's time, attention and trust. Subscribe to our newsletters: https://t.co/JCzYNLRRbk", "geo_enabled": true, "screen_name": "axios", "listed_count": 8111, "friends_count": 964, "is_translator": false, "notifications": false, "statuses_count": 105568, "default_profile": true, "followers_count": 606830, "translator_type": "none", "favourites_count": 626, "profile_image_url": "http://pbs.twimg.com/profile_images/1250736366872395779/NVnHvjJ7_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/800707492346925056/1587033794", "profile_link_color": "1DA1F2", "profile_text_color": "333333", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "withheld_in_countries": [], "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1250736366872395779/NVnHvjJ7_normal.jpg", "profile_background_color": "F5F8FA", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": null, "profile_sidebar_border_color": "C0DEED", "profile_use_background_image": true, "profile_background_image_url_https": null}, "place": null, "id_str": "1483864631240237058", "source": "<a href=\"https://about.twitter.com/products/tweetdeck\" rel=\"nofollow\">TweetDeck</a>", "entities": {"urls": [{"url": "https://t.co/SL1MgmTVGm", "indices": [88, 111], "display_url": "axios.com/exclusive-topo\u2026", "expanded_url": "https://www.axios.com/exclusive-topography-local-clinical-trials-96389357-2c32-42b1-be9b-591aed8dc634.html"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 74292666, "name": "Erin Brodwin", "id_str": "74292666", "indices": [3, 15], "screen_name": "erinbrodwin"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Wed Jan 19 18:11:11 +0000 2022", "coordinates": null, "contributors": null, "retweet_count": 7, "favorite_count": 0, "is_quote_status": false, "retweeted_status": {"id": 1483862686769106947, "geo": null, "lang": "en", "text": "Scoop: Topography charts new trial path with $21.5m from a16z and Bain https://t.co/SL1MgmTVGm", "user": {"id": 74292666, "url": "https://t.co/r55CG7kxT1", "lang": null, "name": "Erin Brodwin", "id_str": "74292666", "entities": {"url": {"urls": [{"url": "https://t.co/r55CG7kxT1", "indices": [0, 23], "display_url": "erinbrodwin.com", "expanded_url": "http://erinbrodwin.com"}]}, "description": {"urls": []}}, "location": "California", "verified": true, "following": false, "protected": false, "time_zone": null, "created_at": "Mon Sep 14 23:00:23 +0000 2009", "utc_offset": null, "description": "health tech \u270d\ufe0f @axios | tips: erin.brodwin at axios dot com 818-679-0610 | ex @statnews @insiderinc @sciam | she/they", "geo_enabled": true, "screen_name": "erinbrodwin", "listed_count": 460, "friends_count": 6409, "is_translator": false, "notifications": false, "statuses_count": 682, "default_profile": false, "followers_count": 12790, "translator_type": "none", "favourites_count": 30508, "profile_image_url": "http://pbs.twimg.com/profile_images/1427877324922363907/2mCH9Pzl_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/74292666/1640104823", "profile_link_color": "7FDBB6", "profile_text_color": "000000", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "withheld_in_countries": [], "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1427877324922363907/2mCH9Pzl_normal.jpg", "profile_background_color": "000000", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme14/bg.gif", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme14/bg.gif"}, "place": null, "id_str": "1483862686769106947", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/SL1MgmTVGm", "indices": [71, 94], "display_url": "axios.com/exclusive-topo\u2026", "expanded_url": "https://www.axios.com/exclusive-topography-local-clinical-trials-96389357-2c32-42b1-be9b-591aed8dc634.html"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Wed Jan 19 18:03:28 +0000 2022", "coordinates": null, "contributors": null, "retweet_count": 7, "favorite_count": 28, "is_quote_status": false, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}